Tarsus Pharmaceuticals (TARS) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026)
Tarsus Pharmaceuticals (TARS) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-13.32% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
17.12% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-14.18% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
24.11% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Tarsus Pharmaceuticals |
2.71 Bn |
2.61 Bn |
152.66 Mn |
534.09% |
| Date | Value |
|---|
| Mar 31, 2026 |
534.09% |
| Dec 31, 2025 |
404.11% |
| Sep 30, 2025 |
140.12% |
| Jun 30, 2025 |
41.99% |
| Mar 31, 2025 |
108.30% |
| Dec 31, 2024 |
57.63% |
| Sep 30, 2024 |
48.27% |
| Jun 30, 2024 |
45.43% |
| Mar 31, 2024 |
12.15% |
| Dec 31, 2023 |
53.40% |
| Sep 30, 2023 |
69.72% |
| Jun 30, 2023 |
60.02% |
| Mar 31, 2023 |
30.38% |
| Dec 31, 2022 |
26.75% |
| Sep 30, 2022 |
83.24% |
| Jun 30, 2022 |
100.21% |
| Mar 31, 2022 |
55.35% |
| Dec 31, 2021 |
37.77% |
| Sep 30, 2021 |
-14.07% |
| Dec 31, 2020 |
255.84% |
